Programa

Dates:

17th, 18th of October 2019

Venue:

Facultad de Medicina.
Universidad
Complutense de
Madrid.
Aula Botella
(1ª planta)

Download Program

October, 17

October 18

9:00
Welcome: Pedro Pérez Segura (Hospital Clínico San Carlos, IdISSC, Madrid)
Session 1: Novel compounds on the horizon
Chairs: Atanasio Pandiella (CIC-Salamanca) and José Ángel García Sáenz
(Hospital Clínico San Carlos, IdISSC, Madrid)
09:20
Strategies to inhibit MYC in cancer
Laura Soucek
Vall D’Hebron Institute of Oncology, Barcelona
09:50
From bench to bedside: the example of CDK4/6 inhibitors
Marcos Malumbres
CNIO, Madrid
10:20
Novel immunotherapies: CAR T cells and bi-specific antibodies
Luis Álvarez-Vallina
Hospital 12 Octubre, Madrid
10:50
Short talk: Targeting Rac-1 SUMOilation: a novel strategy to fight
metastatic cancer?

Sonia Castillo
IdISSC and Universidad Complutense de Madrid, Madrid
11:10
Discussion
12:00
Official Opening
12:15
Professional Achievement Award
Chair: Professor Eduardo Díaz-Rubio
Recipient: Trinidad Caldés Llopis
Session 2: New therapeutic approaches
Chairs: Almudena Porras (Universidad Complutense de Madrid and IdISSC, Madrid) and
Juan Lucio Iovanna (Centro de Investigación del Cáncer, Marselle)
12:25
Cannabinoids as potential anticancer agents
Guillermo Velasco
IdISSC and Universidad Complutense de Madrid, Madrid
13:00
Short talk: Exploring new approaches to target metastatic cancer
by using CRISPR Cas9 libraries

Álvaro Gutiérrez
IdISSC and Universidad Complutense de Madrid
13:20
Short talk: Detecting and targeting tumor dormant cells
Paloma Bragado Domingo
IdISSC and Universidad Complutense de Madrid
13:40
Discussion
14:00
Lunch
Session 3: Translational Oncology: biomarkers for patient selection
Chairs: Carlos Aguado de la Rosa (Hospital Clínico San Carlos, Madrid) and
Joaquín Martínez (Hospital 12 Octubre, Madrid)
16:00
Targeting non-oncogenic alteration: protein degradation
Rajesh Chopra
Institute Cancer Research, London
16:30
Hereditary breast cancer: from mutations to clinical practice
Miguel de La Hoya
Hospital Clínico San Carlos, IdISSC, Madrid
17:00
Rewiring metabolic pathways as a strategy to fight cancer
Arkaitz Carracedo
CiC BIOgune, Derio
17:30
Discussion
17:45
Coffee Break
Session 4: Translation of academic findings to the clinic
Chairs: Pedro Pérez Segura (Hospital Clínico San Carlos, IdISSC, Madrid) and
Arkaitz Carracedo (CiC Biogune, Derio)
18:15
Novel therapies in breast cancer: from the bench to the bedside
Alberto Ocaña
Hospital Clínico San Carlos, IdISSC, Madrid
18:45
Novel therapies for the treatment of Liver cancer
Mari Luz Martínez Chantar
CIC-Biogune, Derio
19:15
Deciphering the vascular complexity of gliomas to unravel this disease
Pilar Sánchez Gómez
ISCIII, Madrid
19:45
Discussion
9:00
Chairs: Guillermo Velasco (IdISSC and Universidad Complutense de Madrid, Madrid) and
Pier Paolo Pandolf (Harvard Medical School, Boston)
Session 5: Clinical implementation of novel therapies
Chairs: Eduardo Díaz Rubio (Hospital Clínico San Carlos, IdISSC) and
Juan Jesús Cruz Hernández (Hospital de Salamanca)
10:00
Novel immunotherapies in lung cancer
Jon Zugazagoitia Fraile
Hospital 12 de octubre. Madrid
10:30
New Approaches in colorectal cancer
Ramón Salazar
ICO. Barcelona
11:00
Molecular Profiling in Breast Cancer
Fernando Moreno Antón
Hospital Hospital Clínico San Carlos, Madrid
11:30
Discussion
11:45
Coffee Break
Session 6: Bioinformatics
Chairs: Fátima Al-Sharoiur (CNIO, Madrid, Spain) and
Pedro Carmona (GENYO)
12:15
Clinical artificial intelligence: separating facts from fiction
Ignacio Hernández Medrano
Medical Savana
12:45
Bioinformatics and Personalized Medicine
Balázs Győrffy
Institute of Enzymology, Budapest
13:00
Discussion
13:15
Keynote lecture on personalized clinical oncology
Chair: Alberto Ocaña (Hospital Clínico San Carlos, IdISSC, Madrid) and
Paul Workman Institute Cancer Research (ICR), London
14:15
Closing Remarks
0